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Pharmacists in Aged Care Facilities
The expression “Home-based care” or basically home care might 
be characterized as a wide exhibit of various kinds of care gave in 
the home by a wide scope of gatherings. The continuum of various 
sorts of home-based care conveyed in the home shifts as far as 
various measurements, including sharpness, kind of care gave, and 
level of physician contribution. Home-based care incorporates both 
formal and casual individual care services, Medicare gifted home 
health, physician house calls, and even “emergency clinic at-home” 
services. Prescription related issues are essential among home 
care patients who take various drugs and have complex medical 
annals and medical issues. The destinations of home social protec-
tion organizations are to help individuals with improving limit and 
live with progressively noticeable opportunity; to propel the client’s 
optimal element of thriving; and to assist the patient with staying 
at home, keeping up a vital good way from hospitalization or ad-
mission to long haul care establishments. Home care is a game 
plan of care given by capable specialists to patients in their homes 
under the heading of a doctor. Home restorative services organi-
zations join nursing care; physical, word related, and talk language 
treatment; and medical social organizations. Doctors may suggest 
patients for home therapeutic services organizations, or the orga-
nizations may be requested by relatives or patients. The extent of 
home human services benefits a patient can get at home is end-
less. Contingent upon the individual patient’s condition, care can 
reach out from nursing care to explicit medical organizations, for 
instance, research center workups. Essential investigations among 
home therapeutic services patients consolidate circulatory disease, 
coronary ailment, harm and hurting, musculoskeletal and connec-
tive tissue disease and respiratory disease.
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Introduction 
The extent of pharmacy services accessible in 
home-care keeps on extending. Pharmacists 
give a wide scope of meds, alongside health and 
improving guides, for patients at home. 
Generally community pharmacists have been 
seen as suppliers of solution and 
nonprescription prescriptions managed orally. 
Today pharmacists in community and 
emergency clinic drug stores the nation over 
have extended their services for the homebound 
patient and give an assortment of advanced 
items and services in the patient's home. 
Community pharmacists give home health 
services including prescription compromise and 
instructing. Pharmacists must adjust their 
communication to address the wide assortment 
of patients' medication related issues during 
these home visits and accomplish 
understanding centered communication. Little is 
thought about the themes examined during a 
post-release home visit and most examinations 
researching quiet pharmacist communication 
concentrated basically on single direction 
pharmacist data arrangement, for example the 
degree to which pharmacists counsel patients, 
and their communication style, for example 
manner of speaking. Quiet centered 
communication is related with expanded 
patients' fulfillment, better review of data and 
improved health results and requires dynamic 
interest of both the pharmacist and the patient. 
Patients ought to be urged to express their 
needs and concerns with respect to their 
prescription, which pharmacists should deliver to 
help patients in settling on educated choice. 
Current points of view to consider in building up 
or assessing clinical pharmacy services offered 
in a home care setting include: staff competency, 
perfect objective patient populace, staff safety, 
utilization of innovation, collaborative 
associations with other health care suppliers, 
exercises performed during a home visit, and 
pharmacist autonomy. Picking up understanding 
in the communication during these home visits 
could be significant for streamlining these visits; 
and therefore, to improve tolerant safety at 
readmission to essential care. A home visit 
protocol empowers pharmacists:  
▪ To address known major challenges during 
the transition from hospital to primary care 
▪ To address patient’s dissatisfaction about 
health care is important as it facilitates 
patient participation during consultation and 
acceptance of pharmacists’ advices 
▪ To discuss patients’ medication beliefs and 
adherence issues more frequently, which 
might be facilitated by additional pharmacist 
training and increasing patient engagement. 
Client Recruitment and Home Visits 
Upon admission to the office, any home care 
client taking at any rate nine prescriptions, 
including OTC and herbal items, is offered a 
pharmacist home visit. Preceding the home visit, 
the pharmacist reviews the client's summary of 
mentioned meds and diagram notes from other 
home care clinicians, for instance, chaperons, 
word related advisors, and physical specialists. 
In the midst of the home visit, the pharmacist 
analyzes each drug, including OTC things and 
natural improvements, with the client and 
caregiver to assess their sign, sufficiency, 
prosperity, and consistence, including 
sensibility. After the fundamental home visit, the 
pharmacist contacts the client's prescriber with 
any proposals for overhauling drug treatment. 
This correspondence is done by electronic 
prosperity record, telephone, or fax. 
Fundamental recommendations fuse stopping 
futile or duplicate treatments or changing 
medication divides. Follow-up care is made by 
the pharmacist and medical attendant [3].  
Benefits of the Pharmacy Home Visit 
Program 
Although nurses and therapist, depending on 
client need and orders, assess all of a client's 
needs, the pharmacist is able to focus primarily 
on medications. Through the MOCH program, 
pharmacists and pharmacy technicians working 
with their health and social care colleagues and 
care homes staff, patients and their families, can 
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provide a number of benefits for care homes and 
their residents including: 
▪ Optimizing medicines (stopping 
inappropriate or unsafe medicines, and 
ensuring medicines add value to patient’s 
health and well-being) 
▪ Patient centered care (shared decision 
making about which medicines care home 
residents take and stop) 
▪ Creating better medicines systems for care 
homes to reduce waste and inefficiency 
▪ Training and supporting care home staff to 
enhance safer administration of medicines 
(NHS England). 
▪ Available studies have shown decreased 
health care utilization, decreased costs to the 
health system, and improved medication 
management with pharmacy involvement in 
home care. 
▪ Beneficial patient outcomes of pharmacy 
practice in home care settings, such as 
decreased hospital admissions, decreased 
emergency department visits, improved 
quality of life, improved compliance, and 
decreased adverse events, have been 
described in many developed countries. 
▪ Positive effects of pharmacy practice in 
ambulatory care settings, such as decreased 
benzodiazepine use, improved anxiety 
scores, improved cardiac outcomes, and 
improved compliance. 
▪ Most home care pharmacy programs in 
developed countries provide several 
services, including comprehensive or 
targeted medication reviews; education for 
patients, families, and staff; and provision of 
drug information [5]. 
 
 
Figure 1. Patient Care Transition from Hospital to Home [1].  Poor transitions of care between 
settings can affect patient outcomes, even cause harm. Patients and their caregivers may be 
confused or overwhelmed, and may not understand what to expect, what medications to take, or 
how to address their needs during transitions. Poorly executed care transitions can lead to adverse 
events, unnecessary readmissions, reduced quality of life, and unneeded use of resources. 
“Transitional care is universal. It doesn't matter whether you have a brain injury, or had a hip 
replacement, a stroke, or a spinal-cord injury. A smooth transition is really important for reducing the 
number of re-hospitalizations” --Minna Hong, Patient Partner, Peer Support Manager, Shepherd 
Center. 
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Figure 2. Elements of successful transitional care models [2]. The care plan should include how 
these needs would be met and by whom. After older persons are discharged from hospital and back 
at home again, they often have to adjust and cope with possible repercussions due to illness and 
health problems.  Many encounter a variety of problems within the first week back at home, a 
particularly vulnerable period. The most commonly reported overall adverse event for older persons 
in several countries is related to medicine treatment, which also causes a considerable number of 
readmissions. Therefore, competence among involved care professionals has been shown to 
Moreover, collaboration and multidisciplinary approaches are also highlighted as well as 
communication among professionals.  
 
 
Figure 3. Cogwheels of Transition [4]. Each and every cog must be synchronized and 
appropriately placed for a seamless, effective and safe care transition. During times of transition, 
the pharmaceutical care patients receive is often suboptimal and wrought with danger. Home 
healthcare nurses play a pivotal and important role in providing transitional care to patients by 
identifying and resolving medication discrepancies. Nurses must partner with pharmacists, 
physicians, and others involved with care transitions to decrease the likelihood of patients 
experiencing untoward health consequences associated with medications.  
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Figure 4. Flow diagram of Refer-to-Pharmacy and Pharmacy Home visit Protocol [6]. Once 
a referral is accepted, the community pharmacist can then contact the patient to arrange a 
mutually convenient time for them to visit the pharmacy for their consultation. The pharmacist 
may then prepare effectively for the consultation as they have a copy of the patient’s discharge 
letter. The strap line for Refer-to-Pharmacy is “get the best from your medicines and stay healthy 
at home” which in lay speech means “medicines optimization”. In March 2015 the NICE published 
Medicines Optimization guidance, which amongst other things states: “a consenting person’s 
medicines discharge information should be shared with their nominated community pharmacy”. 
Refer-to-Pharmacy provides the tool to make this possible, and to so routinely for every eligible 
patient. 
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Common MRPs and Success of Pharmacy 
Visits at Home 
Traditionally, nursing homes have been 
associated with suboptimal drug therapy and 
MRPs. In contrast, less is known about drug 
safety in homecare. Significantly more MRPs 
were detected among patients receiving home 
nursing care than patients living in nursing 
homes. While patients living in nursing homes 
were often undermedicated, documentation 
discrepancies were more frequent in home-
nursing care. MRP categories leading to 
changes on the medication lists differed 
between the settings. 
▪ Untreated conditions: The patient has a 
medical condition that requires drug therapy 
but is not receiving a drug for that condition. 
▪ Drug use without indication: The patient is 
taking a medication for no medically valid 
condition or reason. For example, a client 
may be taking proton-pump inhibitor 
although he or she does not have a history of 
gastroesophageal reflux disease or peptic 
ulcers. Conversely, a client with hypertension 
and diabetes mellitus may not be taking 
aspirin, although he or she has an indication 
for it. 
▪ Improper drug selection: The patient’s 
medical condition is being treated with the 
wrong drug or a drug that is not the most 
appropriate for the patient’s special needs. 
▪ Subtherapeutic dosage: The patient has a 
medical problem that is being treated with too 
little of the correct medication. 
▪ Overdosage: The patient has a medical 
problem that is being treated with too much 
of the correct medication. 
▪ Effectiveness: Effectiveness-related 
problems occur when a medication dose is 
too low or when a more effective drug is 
available. For example, a patient with chronic 
pain may be taking acetaminophen when an 
opioid may be more effective. 
▪ ADRs: The patient has a medical condition 
that is the result of an adverse drug reaction 
or adverse effect. In the case of older adults, 
adverse drug reactions contribute to already 
existing geriatric problems such as falls, 
urinary incontinence, constipation, and 
weight loss. 
▪ Safety: When a client is taking a medication 
with a dose that is too high or is taking a 
medication that causes an adverse drug 
reaction, he or she is experiencing a safety 
medication-related problem. For example, a 
client may not be able to take amitriptyline for 
insomnia because anticholinergic side 
effects are too bothersome. 
▪ Drug interactions: The patient has a medical 
condition that is the result of a drug 
interacting negatively with another drug, 
food, or laboratory test. 
▪ Compliance: The patient has a medical 
condition that is the result of not receiving a 
medication due to economic, psychological, 
sociological, or pharmaceutical reasons. 
Compliance-related problems describe 
instances when a client prefers not to take a 
medication, does not understand how to use 
a medication, or cannot afford a medication. 
A client is experiencing a compliance-related 
problem if he or she does not understand 
how to use an inhaler or prefers not to take a 
medication to treat a condition [3], [5,6]. 
▪ The core of the PATCH service is the ability 
of pharmacists to provide comprehensive 
patient-centered care by identifying MRPs 
and making evidence-based 
recommendations to providers to optimize 
medication use. MRPs have been estimated 
to cost approximately $177.4 billion per year 
and are estimated to be one of the top 5 
causes of death in the elderly population. 
Identifying, resolving, and preventing MRPs 
can lead to cost savings as well as improved 
patient outcomes [7,8]. Traditionally, the 
availability of clinical pharmacy services has 
been in the purview of hospitals where 
increased clinical pharmacy services has 
been associated with reduced length of stay 
and mortality. Recognition of the value of the 
role of the pharmacist has resulted in 
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expansion of clinical services into outpatient 
settings, including patient homes. For 
example, the HMR program that was 
established in Australia in 2001 provides 
funding for pharmacists to visit patients at 
home to assess their medication regimens. In 
Canada, provincial governments are 
compensating pharmacists for providing 
medication reviews (MRs) for non-
hospitalized patients and also authorizing 
pharmacists to prescribe [9]. 
 
 
Figure 5. Pharmacist Advancement of Transitions of Care to Home (PATCH) service workflow 
depicting steps to optimize medication safety for high-risk patients [7]. During the pharmacist 
meeting, a comprehensive medication review, BP and glucose log review, medication reconciliation, 
and allergy assessment are performed. Additional patient education is provided through verbal 
discussion and disease state management pamphlets. The pharmacist then discusses all MRPs 
identified with the PCP immediately after the pharmacist session and a medication plan is 
formulated. Recommendations are also documented within the EMR in the PCP encounter and are 
available for the PCP to review prior to the face-to-face visits with the patients. After the PCP visit, 
patients are provided with a post-visit summary sheet reinforcing educational points from both the 
pharmacist and PCP sessions as well as an updated medication list. Follow-up visits with the 
pharmacist are scheduled, if the patient requires additional education and/or management based 
on the clinical judgment of the PCP or pharmacist. 
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Residential Care Pharmacists into Aged Care 
Homes 
Prescribing in the residential aged care 
population is complex, and requires ongoing 
review to prevent medication misadventure. 
Integrating an on-site clinical pharmacist into 
residential care teams is an unexplored 
opportunity to improve quality use of medicines 
in this setting. Pharmacist-led medication review 
is effective in reducing medication-related 
problems; however, current funding 
arrangements specifically exclude pharmacists 
from routinely participating in resident care [10]. 
Medication Use in Older Adults 
Prescribing in the older population is highly 
complex. Age-related pharmacokinetic and 
pharmacodynamic changes lead to variations in 
drug bioavailability, increased drug sensitivity, 
and decreased regulatory mechanisms, altering 
the effects of drug usage from those observed in 
younger populations. In addition, the presence 
of multiple co-morbidities necessitating multiple 
medication usage equates to an increased risk 
of medication misadventure in older adults. 
Advancing age is positively correlated with 
increased prevalence of chronic disease, and 
increased number of co-morbidities correlates 
with increased medication use [11-15]. ADEs 
can significantly impair occupational and 
cognitive functioning, and quality of life. All 
medications have the potential to cause an ADE, 
particularly in older adults, as a result of 
pathophysiological decline, inappropriate 
polypharmacy, and involvement of multiple 
health providers. This can worsen cognitive 
impairment, frailty, disability, frequency of falls, 
and mortality [14,15].  
Transitions of Care and ADEs 
Transitioning into aged care has been identified 
as a particularly high-risk point where residents 
are vulnerable to medication errors and ADEs. 
Transitions of care for residents include new 
admission from the community or hospital to a 
RACH, or returning to the RACH post-discharge 
from hospital. Poorly executed care transitions 
and miscommunication can result in interrupted 
continuity of care and adverse events, which 
may lead to inappropriate re-admission to 
hospital or presentation to emergency 
departments. A study shows Hypertension 
(nearly 50%%) was the highest prevalent 
chronic disease among the study participants 
followed by osteoarthritis (35%), diabetes 
mellitus (more than 25%), respiratory disorders 
(14%) and cerebro-vascular accidents (11%) in 
old-age homes of Malaysia. Approximately 20% 
of residents experience a significant delay in 
medication administration and missed doses 
following admission or re-admission to a RACH. 
Transition-related medication errors are 
observed in 13–31% of RACH residents, often 
involve high risk medications, such as warfarin, 
insulin, psychoactive agents, and opioids, and 
have greater risk of causing serious harm to the 
resident [16-19]. 
Communicable Disease Prevention 
Five most common infections in the elderly are 
UTIs, GI infections, Bacterial pneumonia and 
influenza. Viral infections like herpes zoster 
(shingles), pressure ulcers, bacterial or fungal 
foot infections (which can be more common in 
those with diabetes), cellulitis, drug-resistant 
infections like MRSA are common skin 
infections. More than 60% of seniors over 65 get 
admitted to hospitals due to pneumonia, 
reported by AAFP (underlying causes are 
changes in lung capacity, increased exposure to 
disease in community settings, and increased 
susceptibility due to other conditions like 
cardiopulmonary disease or diabetes). Influenza 
and pneumonia combined add up to the sixth 
leading cause of death in America — 90% of 
these in senior adults. Weakened immunity in 
the elderly, along with other chronic conditions, 
increases the risk of developing severe 
complications from influenza, such as 
pneumonia. Because influenza is easily 
transmitted by coughing and sneezing, the risk 
of infection increases in a closed environment 
like a nursing home. Cough, chills and fever are 
the common symptoms, though, again, influenza 
may present different signs in older adults. 
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Influenza is largely preventable through annual 
vaccination, and there is sufficient evidence to 
support RACH staff vaccination to protect 
residents from influenza. The rational for this is 
to improve accessibility to the vaccination for 
members of the community who have difficulty 
accessing the vaccine through their GP or 
employer, as pharmacies are often open later 
and on weekends [20-23].  
Terminal/Palliative Care 
Palliative care in U.S. hospitals increasing every 
year, according 2018 Palliative Care Growth 
Snapshot issued by the Center to Advance 
Palliative Care (CAPC). The prevalence of 
hospitals (50 or more beds) with a palliative care 
team increased from 658 to 1,831–a 178% 
increase from 2000 to 2016 [24]. And By 2056, 
480,000 Canadian deaths per year are predicted 
with 90% of those deaths being eligible for 
palliative care [25]. Patients diagnosed with a 
terminal illness often require nonstandard doses 
that are not available commercially, so 
pharmacists caring for hospice patients may 
need to compound products to meet individual 
patients’ unique needs [26,27]. This may include 
formulating preparations that are flavored to 
overcome undesirable characteristics or 
producing dosage forms with alternative 
ingredients and/or excipients to avoid allergic 
reactions or progressive intolerances. 
Pharmacists can often recommend dosing 
devices that help patients and caregivers deliver 
the proper dose of highly potent medications. 
Such devices might not otherwise be readily 
available to patients in the community [28]  
Transition of Care: Issue of Collaboration  
Improving medication management during care 
transitions will require 3 main initiatives. First, 
the patient must remain the central focus of care. 
Second, interprofessional communication and 
collaboration need to occur among all providers 
involved in the health care of individual patients. 
Third, the outcomes of pharmacist involvement 
during care transitions needs to be evaluated 
systematically (ideally in controlled trials) to 
demonstrate a cost-effective improvement in 
quality and to provide financial justification for 
investing in pharmacist resources. Collaboration 
between hospital and community pharmacists 
can also facilitate patient-centered care. Multiple 
medication changes during hospitalization can 
be confusing to patients, caregivers, and 
providers, and can lead to medication errors. 
Hospital pharmacists can provide a reconciled 
medication list and meet with patients for 
counseling and education. Typically, the day of 
discharge is busy, and patients have limited time 
and attention to discuss important issues. A 
“hand-off” or pharmacist discharge care plan 
could facilitate the coordination of medication 
management between the hospital and 
community pharmacist. This provides continuity 
so that the community pharmacist has a list of 
actual or potential medication-related problems 
to follow-up on with the patient or other health 
care providers. It also provides the community 
pharmacist with patient information that they 
would not normally have access to [29]. 
Resources should be targeted toward patient 
populations at increased risk for readmission, 
such as patients with heart failure, COPD, 
asthma, advanced age (discussed earlier), low 
health literacy, and frequent hospitalizations 
(FEs). 
Heart Failure Management 
Community pharmacists who expand their roles 
and make home visits to heart failure (HF) 
patients after hospital discharge can improve 
outcomes. Home health care teams rarely 
include pharmacists when they provide care to 
patients undergoing transitions in care. HF 
affects approximately 6 million adults in the USA, 
with more than $30 billion in associated annual 
costs; by 2030, these figures are expected to 
rise to more than 8 million adults and more than 
$69 billion. From 2012 to 2014, the age-adjusted 
rate of HF-related deaths per 100,000 people 
increased from 81.4 to 84.0. The impact of 
pharmacist intervention was evaluated in a 
pharmacy-led TOC program for patients with HF 
from a US hospital. The goal of TOC is to help 
recently-discharged patients avoid unnecessary 
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hospital and emergency room re-admissions 
while ensuring quick healing and recovery right 
at home. Their primary functions are in-home 
medical care, collaboration and communication 
with patient’s primary care provider, specialist 
and discharging hospital, discharge summary 
review, lab testing & diagnostic imaging, 
medication reconciliation & adherence etc. 
Admission medication reconciliation and 
discharge medication review were performed to 
monitor for appropriateness and dosing, 
duplications, omissions, and drug interactions. 
Pharmacy-led TOC increased compliance with 
HF core measures (including appropriate 
medication use) and reduced HF readmissions, 
30-day readmissions, all-cause readmissions, 
and costs [31-33]. 
 
 
Figure 6. The Seven Elements for a Safe Transition to Occur [30]. Seven elements that must be 
in place for a safe transition to occur from one health setting to another include: leadership support; 
multidisciplinary collaboration; early identification of patients/clients at risk; transitional planning; 
medication management; patient and family action/engagement; and the transfer of information. The 
Joint Commission has incorporated transition measures into their disease specific care certification 
programs as a component to ensure excellence in the delivery of healthcare services for several 
designated conditions.  The Joint Commission have developed videos to help clinicians improve 
patient transfer communication skills www.jcrinc.com/improving-transitions-of-care-videos/  
 
COPD Management 
COPD, the fourth leading cause of death 
worldwide, is also a major cause of chronic 
morbidity all over the world, particularly in 
developing countries. In 2016, it was the third 
leading cause of years of life lost and disability-
adjusted life-years in the United States, with an 
estimated 164 000 deaths. Indeed, in 2012, 
more than 3 million people worldwide died of 
COPD, equating to 6% of all deaths globally in 
that year. In the UK, the costs associated with 
COPD are estimated to exceed £800 million. In 
the USA, more than 26 million people are 
estimated to have COPD but almost half of these 
are undiagnosed. The significance of effective 
COPD exacerbation management is critical to 
managing healthcare resources.  Clinical 
improvement depends on many factors such as 
drug selection, patient compliance and control of 
other risk factors including the environment and 
nutrition. Patients at risk for having an 
exacerbation of COPD should receive self-
management strategies. Prompt therapy prior to 
exacerbations reduces hospital admissions and 
readmissions, speeds recovery, and slows 
disease progression. COPD patients tend to 
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have better medication adherence with 
pharmacist counseling, subsequently improving 
their quality of life as well as clinical outcomes. 
Direct education by pharmacists has been 
shown to be more effective than other teaching 
methods, including watching videos and 
providing inhaler pamphlets. With increasing 
number of COPD patients, individualized 
counseling for patients is a challenge to the 
limited number of physicians. Incorrect use of 
inhalers is very common and subsequently leads 
to poor control of COPD. Pharmacist-led 
comprehensive inhaler technique intervention 
program using an unbiased and simple scoring 
system can significantly improve the inhaler 
techniques in COPD patients. A 3-month 
combined program of transition and long-term 
self-management support resulted in 
significantly fewer COPD-related 
hospitalizations and emergency department 
visits and better HRQL at 6 months after 
discharge [34-40]. 
 
Exhibit 1. Frequent Hospitalization and Risk of AECOPD [41] 
Frequent exacerbations (FEs) mean that the disease is progressing faster, 
increasing the risk of acute re-exacerbation and mortality. Recent studies showed 
that ≥2 events/year of AECOPD or ≥1 event/year of AECOPD leading to 
hospitalization was the risk factor for future exacerbation events. The COPDGene 
study showed that wall thickness and emphysema were involved in AECOPD and 
were independent of airflow limitation. Among others, wall thickness and EI, two 
imaging features, are well-accepted indicators reflecting the pathological changes 
of COPD. Exacerbation hospitalizations in the past year and EI were independently 
associated with hospitalization. A cohort study shows that with the increase in the 
number of hospitalizations, the risk of acute exacerbation and death increased in 
turn.  
 
Hip/Knee Arthoplasty 
THA and TKA, collectively known as TJA, are 
beneficial and cost-effective procedures for 
patients with symptomatic osteoarthritis. The US 
health care system is the costliest in the world – 
accounting for 17% of GDP – estimates that 
percentage will grow to nearly 20% by 2020. TJA 
is the single largest cost in Medicare, with 
reports showing a $13.43 billion annual price tag 
for THAs, and a $40.8 billion annual price tag for 
TKAs. 20% of readmissions occur due to a 
medication error, 60 % of all medication errors 
occur during times of care transitions. The most 
common cause of unplanned readmission at 
both 30 and 90 days post-THA were joint-
specific reasons, including dislocation and joint 
malfunction. The second and third most 
common causes for unplanned readmission, 
again at both 30 and 90 days, were surgical 
sequelae and thromboembolic disease, followed 
by surgical site infection. the pharmacologic 
intervention directly related to the procedure 
post-surgery is often limited to pain 
management (most commonly opioid 
analgesics).  Unlike chronic disease 
management, the effect of proper pain manages 
- mint tends to be more tangible to the patient. 
When non-adherent to the pain management 
regimen, the resulting symptoms tend to be 
incentive enough for the patient to become 
adherent until the operative pain is resolved 
permanently [42-46]. 
Transitional Care Needs of LHL in 
Hospitalization 
Hospitalization represents a crucial care 
transition point for patients with exacerbations of 
chronic disease, in which patient education can 
aid in improving disease management and 
reducing negative health outcomes after 
discharge, such as readmissions and discharge 
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medication errors. Resources may be limited for 
in-hospital patient education, so triaging by HL 
level may be necessary for resource-
optimization. LHL affects approximately 30% to 
60% of adults in the US, Canada, Australia, and 
the EU. Screening for inadequate health literacy 
and associated needs may enable hospitals to 
address these barriers and improve post-
discharge outcomes. Health literacy is 
associated with many factors that may affect 
successful navigation of care transitions, 
including doctor-patient communication, 
understanding of the medication regimen, and 
self-management). Research has also 
demonstrated an association between low 
health literacy and poor outcomes after hospital 
discharge (misunderstanding discharge 
instructions, poor self-rated health, self-efficacy, 
and decreased use of preventative services), 
including medication errors, 30-day hospital 
readmission, and mortality. Potential ADEs are 
also common and arise from unintentional 
discrepancies between admission and 
discharge regimens, such as changes in dose, 
route, or frequency, and/or introduction of new 
medications. Transitional care initiatives have 
begun to incorporate health literacy into patient 
risk assessments and provide specific attention 
to low health literacy in interventions to reduce 
adverse drug events and readmission. Patients 
– particularly those with limited health literacy – 
found a hospital pharmacist-based intervention 
to be very helpful and empowering. The PILL-
CVD study consisting of pharmacist-assisted 
medication reconciliation, inpatient pharmacist 
counseling, low-literacy adherence aids, and 
individualized telephone follow-up, on the 
number of clinically important medication errors 
after hospital discharge suggested more 
involvement of pharmacists and opportunities for 
better outcome [47-50]. 
End-stage renal disease (ESRD) and 
Transition Care 
In the case of non-ESRD CKD, the utilization of 
HC may vary based on patient’s age and 
comorbidities and, in the case of ESRD, it may 
vary based on the severity of illness and therapy 
type. Providing end-of-life care to patients 
suffering from chronic kidney disease (CKD) 
and/or end-stage renal disease often presents 
ethical challenges to families and health care 
providers. Approximately 40% of patients >75 
years of age are affected by CKD, and dialysis 
initiation is highest in patients ≥65 years of age. 
Many patients who receive dialysis also suffer 
from multiple comorbidities, and 1-year mortality 
rates following initiation of dialysis is 41% in 
patients ≥75 years of age [51]. HC services may 
help in supporting ESRD patients who have 
chosen conservative care. Up to 15% of older 
adults with CKD stage 5 opt for conservative 
management, with conservative management 
increasingly being recognized as an acceptable 
and beneficial treatment option [52]. The 
independent treatment modalities for ESRD 
(peritoneal dialysis, PD, and home 
hemodialysis, HHD), emphasized as viable 
alternatives to facility-based treatment 
modalities over the last decade, are less costly 
to direct service providers, with equivalent or 
superior patient outcomes and quality of life [53]. 
Having an interdisciplinary palliative team in 
place to address any concerns that may arise 
during conversations related to end-of-life care 
encourages effective communication between 
the patient, the family and the medical team. 
One aspect that remains largely unaddressed at 
a systemic level is the high-risk transition period 
from chronic kidney disease and acute kidney 
injury to permanent dialysis dependence. 
Incident dialysis patients experience 
disproportionately high mortality and 
hospitalization rates coupled with high costs 
[54].  
Prevention of Hospital Readmissions 
Most common cases of hospital readmissions in 
US are heart failure, heart attack, and 
pneumonia, hip and knee replacements, 
exacerbations of COPD; heart bypass. The 
penalties were capped at 1% of Medicare 
reimbursements in 2013, 2% in 2014, and 3% in 
2015. The government estimates that the 
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penalties for fiscal year 2015 will total $424 
million and affect 2,638 hospitals, representing 
an average penalty of more than $160,000 per 
hospital. Nearly 20% older adults are readmitted 
to a hospital within 30 days of discharge. Given 
that more than half of these readmissions are 
preventable, the new penalties are compelling 
hospitals to make the reduction of readmissions 
a priority. The community liaison pharmacist 
provides the missing link between hospital care 
and the home, as well as among different health 
care providers, thereby minimizing admission to 
the hospital due to medication mismanagement 
and promoting appropriate allocation of health 
care resources. And community pharmacists, 
the health care professionals who have the most 
interaction with patients’ post-discharge, are 
often underutilized. Being an integral part of the 
transition-of-care process, pharmacists can not 
only show their value but move the pharmacy 
profession toward being recognized as 
comprising health care providers. Community 
liaison programs clearly help reduce hospital 
readmissions and other types of harm and 
wasted resources associated with preventable 
adverse drug events [56-59]. 
 
 
Figure 8. Dialysis facility-centered medication management services model [55]. In this model 
of care delivery, a pharmacist can provide crosscutting medication management services by 
communicating bidirectionally between the dialysis unit team and the patient’s care providers, family, 
and payers, closing the loop of communication, improving medication list accuracy, and identifying 
and resolving MRPs. The pharmacist in this model could function like a consultant, providing 
medication management services to patients in several dialysis units. 
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The Future Home Care 
Shocking as it sounds, 50 million Americans will 
be 65 years old or older by 2020, representing 
17% of the population [60]. More than 70% of 
patients of the Mobility Clinic reported improved 
access to care when their condition worsened 
[61]. Nearly one-third of older home health care 
patients have a potential medication problem or 
are taking a drug considered inappropriate for 
older people [62]. The demand for informal 
caregivers is expected to rise by more than 85% 
over the next few decades due to the growing 
population of older adults, many of whom will 
experience significant functional impairment 
related to chronic illness [63]. Over 30% of the 
patients requiring in-home care are either 
disabled or suffering from a chronic health 
condition that requires patient aid. Many home 
healthcare services often refuse new patients 
only due to lack of sufficient staff [64].  HH (home 
health) care agencies serving 3.4 million 
Medicare beneficiaries at a cost of 17.9 billion 
U.S. dollars [65]. It is estimated that, of the 38.2 
million adults age 65 and older in the United 
States, more than a quarter (29%) receive 
assistance for health or functioning reasons. The 
burdens of caregiving include physical, 
psychological, and financial hardships, and can 
have serious consequences for caregivers’ 
overall health, immune functioning, and 
longevity [66]. All these practical situations 
clearly define the scope and features of future 
home health skilled medicare which is paid for 
under the Medicare home health benefit and 
delivered by Medicare-certified home health 
agencies. Home health care is one type of 
home-based care. A subset of home health 
providers is already developing these 
capabilities and can be seen as harbingers of the 
future for how home health providers may 
ultimately progress and experience risk-based 
payments. Many of the providers focusing on 
specific clinical conditions, most often chronic 
obstructive pulmonary disease (COPD), 
congestive heart failure (CHF), and diabetes. 
Medicare officials have already signaled their 
willingness to enable some flexibility in new 
payment models when providers have a 
financial stake in their performance against 
quality and cost targets; however, current 
challenges and structures do not allow home 
health care to be used optimally [67].  
Conclusion 
Community pharmacists are among the most 
accessible front-line primary care practitioners 
and are well positioned to affect the care of 
homebound patients. Pharmacist-directed home 
medication reviews offer an effective 
mechanism to address the pharmacotherapy 
issues of those members of the community who 
are most in need but may otherwise lack access 
to pharmacy services. As the general population 
ages, the demand for such services will 
undoubtedly increase. Pharmacist-directed 
home medication reviews could serve to 
minimize inappropriate use of medication, 
maximize health care cost savings and expand 
the scope of pharmacy practice 
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pulmonary disease (COPD); Acute Exacerbation 
of COPD (AECOPD); Low Health Literacy (LHL); 
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(HF); Frequent Exacerbation (FEs); 
Emphysema Index (EI); Total Hip Arthroplasty 
(THA); Total Knee Arthroplasty (TKA), Total 
Joint Arthroplasty (TJA); National Institute for 
Health and Care Excellence (NICE); current 
procedural technology (CPT); myocardial 
infarction (MI); Primary Care Physician (PCP) 
Article Summary 
The provision of home care has existed since the 
turn of the last century, when societal concerns 
regarding immigration, industrialization, and 
infectious diseases spawned the need for 
visiting nurses. Early homecare services 
primarily consisted of midwife and nursing 
assistance for births, and the care of influenza 
and tuberculosis patients. This early form of 
home care paved the way for the development 
of alternate site healthcare. In the past, the term 
home care generally referred to community-
based nursing services provided to patients in 
their homes. Today, the term has been 
expanded to include home/alternate site 
healthcare and encompasses: long-term care, 
and skilled nursing facilities, assisted living and 
subacute facilities, home care, diagnostic 
centers, outpatient clinics, ambulatory surgery, 
rehabilitation facilities, and emergency service 
markets. 
 
 
Figure 9. Framework for home health of the future [67]. Home health agencies of the future must 
provide care that is: (1) Patient and person centered (2) Seamlessly connected and coordinated (3) 
High quality (4) Technology enabled. Three critical roles for the home health agency of the future 
(1) Post–acute care and acute care support (2) Primary care partners (3) Home-based long-term 
care partners. The home health agency of the future increasingly has new payment incentives and 
shared savings contracts for per - forming   these   roles   capably   and   efficiently.   In   many    
instances, the home health agency of the future is structurally and formally more connected (as the 
owners, partners, or   subsidiaries) of entities that integrate a range of home-based services beyond 
home health agency care. 
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Article Highlights  
1. MRPs have been estimated to cost 
approximately $177.4 billion per year and are 
estimated to be one of the top 5 causes of death 
in the elderly population. 
2. Approximately 20% of residents experience a 
significant delay in medication administration 
and missed doses. 
3. More than 60% of seniors over 65 get 
admitted to hospitals due to pneumonia, 
reported by AAFP. 
4. Influenza and pneumonia combined add up to 
the sixth leading cause of death in America — 
90% of these in senior adults. 
5. By 2056, 480,000 Canadian deaths per year 
are predicted with 90% of those deaths being 
eligible for palliative care. 
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